Cargando…
Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease
Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its r...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492079/ https://www.ncbi.nlm.nih.gov/pubmed/30229970 http://dx.doi.org/10.1002/hep.30275 |
_version_ | 1783415076332503040 |
---|---|
author | Blokker, Britt A. Maijo, Monica Echeandia, Marta Galduroz, Mikel Patterson, Angela M. Ten, Anna Philo, Mark Schungel, Rebecca Gutierrez‐de Juan, Virginia Halilbasic, Emina Fuchs, Claudia Le Gall, Gwenaelle Milkiewicz, Malgorzata Milkiewicz, Piotr Banales, Jesus M. Rushbrook, Simon M. Mato, José M. Trauner, Michael Müller, Michael Martínez‐Chantar, María Luz Varela‐Rey, Marta Beraza, Naiara |
author_facet | Blokker, Britt A. Maijo, Monica Echeandia, Marta Galduroz, Mikel Patterson, Angela M. Ten, Anna Philo, Mark Schungel, Rebecca Gutierrez‐de Juan, Virginia Halilbasic, Emina Fuchs, Claudia Le Gall, Gwenaelle Milkiewicz, Malgorzata Milkiewicz, Piotr Banales, Jesus M. Rushbrook, Simon M. Mato, José M. Trauner, Michael Müller, Michael Martínez‐Chantar, María Luz Varela‐Rey, Marta Beraza, Naiara |
author_sort | Blokker, Britt A. |
collection | PubMed |
description | Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its role in cholestatic liver disease. We determined SIRT1 expression in livers from patients with cholestatic disease, in two experimental models of cholestasis, as well as in human and murine liver cells in response to bile acid loading. SIRT1‐overexpressing (SIRT(oe)) and hepatocyte‐specific SIRT1‐KO (knockout) mice (SIRT(hep–/–)) were subjected to bile duct ligation (BDL) and were fed with a 0.1% DDC (3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine) diet to determine the biological relevance of SIRT1 during cholestasis. The effect of NorUDCA (24‐norursodeoxycholic acid) was tested in BDL/SIRT(oe) mice. We found that SIRT1 was highly expressed in livers from cholestatic patients, mice after BDL, and Mdr2 knockout mice (Mdr2(–/–)) animals. The detrimental effects of SIRT1 during cholestasis were validated in vivo and in vitro. SIRT(oe) mice showed exacerbated parenchymal injury whereas SIRT(hep–/–) mice evidenced a moderate improvement after BDL and 0.1% DDC feeding. Likewise, hepatocytes isolated from SIRT(oe) mice showed increased apoptosis in response to bile acids, whereas a significant reduction was observed in SIRT(hep–/–) hepatocytes. Importantly, the decrease, but not complete inhibition, of SIRT1 exerted by norUDCA treatment correlated with pronounced improvement in liver parenchyma in BDL/SIRT(oe) mice. Interestingly, both SIRT1 overexpression and hepatocyte‐specific SIRT1 depletion correlated with inhibition of FXR, whereas modulation of SIRT1 by NorUDCA associated with restored FXR signaling. Conclusion: SIRT1 expression is increased during human and murine cholestasis. Fine‐tuning expression of SIRT1 is essential to protect the liver from cholestatic liver damage. |
format | Online Article Text |
id | pubmed-6492079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-64920792019-05-06 Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease Blokker, Britt A. Maijo, Monica Echeandia, Marta Galduroz, Mikel Patterson, Angela M. Ten, Anna Philo, Mark Schungel, Rebecca Gutierrez‐de Juan, Virginia Halilbasic, Emina Fuchs, Claudia Le Gall, Gwenaelle Milkiewicz, Malgorzata Milkiewicz, Piotr Banales, Jesus M. Rushbrook, Simon M. Mato, José M. Trauner, Michael Müller, Michael Martínez‐Chantar, María Luz Varela‐Rey, Marta Beraza, Naiara Hepatology Original Articles Cholestasis comprises aetiologically heterogeneous conditions characterized by accumulation of bile acids in the liver that actively contribute to liver damage. Sirtuin 1 (SIRT1) regulates liver regeneration and bile acid metabolism by modulating farnesoid X receptor (FXR); we here investigate its role in cholestatic liver disease. We determined SIRT1 expression in livers from patients with cholestatic disease, in two experimental models of cholestasis, as well as in human and murine liver cells in response to bile acid loading. SIRT1‐overexpressing (SIRT(oe)) and hepatocyte‐specific SIRT1‐KO (knockout) mice (SIRT(hep–/–)) were subjected to bile duct ligation (BDL) and were fed with a 0.1% DDC (3,5‐diethoxycarbonyl‐1,4‐dihydrocollidine) diet to determine the biological relevance of SIRT1 during cholestasis. The effect of NorUDCA (24‐norursodeoxycholic acid) was tested in BDL/SIRT(oe) mice. We found that SIRT1 was highly expressed in livers from cholestatic patients, mice after BDL, and Mdr2 knockout mice (Mdr2(–/–)) animals. The detrimental effects of SIRT1 during cholestasis were validated in vivo and in vitro. SIRT(oe) mice showed exacerbated parenchymal injury whereas SIRT(hep–/–) mice evidenced a moderate improvement after BDL and 0.1% DDC feeding. Likewise, hepatocytes isolated from SIRT(oe) mice showed increased apoptosis in response to bile acids, whereas a significant reduction was observed in SIRT(hep–/–) hepatocytes. Importantly, the decrease, but not complete inhibition, of SIRT1 exerted by norUDCA treatment correlated with pronounced improvement in liver parenchyma in BDL/SIRT(oe) mice. Interestingly, both SIRT1 overexpression and hepatocyte‐specific SIRT1 depletion correlated with inhibition of FXR, whereas modulation of SIRT1 by NorUDCA associated with restored FXR signaling. Conclusion: SIRT1 expression is increased during human and murine cholestasis. Fine‐tuning expression of SIRT1 is essential to protect the liver from cholestatic liver damage. John Wiley and Sons Inc. 2019-01-29 2019-02 /pmc/articles/PMC6492079/ /pubmed/30229970 http://dx.doi.org/10.1002/hep.30275 Text en © 2018 The Authors Hepatology published by Wiley Periodicals, Inc. on behalf of American Association for the Study of Liver Diseases. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Blokker, Britt A. Maijo, Monica Echeandia, Marta Galduroz, Mikel Patterson, Angela M. Ten, Anna Philo, Mark Schungel, Rebecca Gutierrez‐de Juan, Virginia Halilbasic, Emina Fuchs, Claudia Le Gall, Gwenaelle Milkiewicz, Malgorzata Milkiewicz, Piotr Banales, Jesus M. Rushbrook, Simon M. Mato, José M. Trauner, Michael Müller, Michael Martínez‐Chantar, María Luz Varela‐Rey, Marta Beraza, Naiara Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease |
title | Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease |
title_full | Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease |
title_fullStr | Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease |
title_full_unstemmed | Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease |
title_short | Fine‐Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease |
title_sort | fine‐tuning of sirtuin 1 expression is essential to protect the liver from cholestatic liver disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492079/ https://www.ncbi.nlm.nih.gov/pubmed/30229970 http://dx.doi.org/10.1002/hep.30275 |
work_keys_str_mv | AT blokkerbritta finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT maijomonica finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT echeandiamarta finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT galdurozmikel finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT pattersonangelam finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT tenanna finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT philomark finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT schungelrebecca finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT gutierrezdejuanvirginia finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT halilbasicemina finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT fuchsclaudia finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT legallgwenaelle finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT milkiewiczmalgorzata finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT milkiewiczpiotr finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT banalesjesusm finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT rushbrooksimonm finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT matojosem finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT traunermichael finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT mullermichael finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT martinezchantarmarialuz finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT varelareymarta finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease AT berazanaiara finetuningofsirtuin1expressionisessentialtoprotecttheliverfromcholestaticliverdisease |